Concord Medical Services shares are trading lower after the company announced plans to change from the current ADS Ratio of 1 ADS representing 3 Class A ordinary shares to a new ADS ratio of 1 ADS representing 30 Class A ordinary shares.

7/11/24 4:04:46 PM ET

Medical/Nursing Services

Health Care

Get the next $CCM alert in real time by email

Get the next $CCM alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CCM

Date	Price Target	Rating	Analyst

More analyst ratings

$CCM
Press Releases

Fastest customizable press release news feed in the world

Concord Medical Schedules 2024 Annual Meeting of Shareholders
BEIJING, Nov. 13, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it will hold its 2024 annual general meeting of shareholders (the "Meeting") on December 27, 2024, at 10:00 a.m. (Beijing Time). The meeting will be held at Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua Road, Chaoyang District, Beijing, China. The shareholder record date is November 27, 2024. A copy of the notice of Meeting is available on the Company's investor relations website at https://ir.ccm.cn. The purpose of the Meeting is
11/13/24 8:00:00 AM ET
$CCM
Medical/Nursing Services
Health Care
Concord Medical Reports Financial Results for the First Half of 2024
BEIJING, Sept. 27, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2024[1]. 2024 First Half Highlights Total net revenues were RMB218.8 million (US$30.1 million) in the first half of 2024, representing a 23.1% decrease from total net revenues of RMB284.5 million in the same period last year. Total net revenues included the net revenues from the hospital business of RMB137.8 million (US$19.0 million) and the net revenues from the network
9/27/24 7:00:00 AM ET
$CCM
Medical/Nursing Services
Health Care
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment
BEIJING, Sept. 16, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that Guangzhou Concord Cancer Center ("Guangzhou Hospital"), a PRC subsidiary of the Company offering comprehensive cancer care services, has obtained the large medical equipment procurement license (the "License") for its proton equipment. As previously disclosed in the Company's annual report for the fiscal year ended December 31, 2023, Guangzhou Hospital has completed the installment of the proton equipment in September 2020 and commenced its cl
9/16/24 8:00:00 AM ET
$CCM
Medical/Nursing Services
Health Care

$CCM
Financials

Live finance-specific insights

Concord Medical Reports Financial Results for the First Half of 2024
BEIJING, Sept. 27, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2024[1]. 2024 First Half Highlights Total net revenues were RMB218.8 million (US$30.1 million) in the first half of 2024, representing a 23.1% decrease from total net revenues of RMB284.5 million in the same period last year. Total net revenues included the net revenues from the hospital business of RMB137.8 million (US$19.0 million) and the net revenues from the network
9/27/24 7:00:00 AM ET
$CCM
Medical/Nursing Services
Health Care
Concord Medical Reports Financial Results for the First Half of 2023
BEIJING, Sept. 22, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023[1]. 2023 First Half Highlights Total net revenues were RMB284.5 million (US$39.2 million) in the first half of 2023, representing a 97.2% increase from total net revenues of RMB144.3 million in the same period last year. Total net rev
9/22/23 5:00:00 PM ET
$CCM
Medical/Nursing Services
Health Care
Concord Medical Reports Financial Results for the First Half of 2022
BEIJING, Sept. 23, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2022[1]. 2022 First Half Highlights Total net revenues were RMB144.3 million (US$21.5 million) in the first half of 2022, representing a 25.2% decrease from total net revenues of RMB192.9 million in the same period last year. Total net reve
9/23/22 4:00:00 PM ET
$CCM
Medical/Nursing Services
Health Care

Concord Medical Services shares are trading lower after the company announced plans to change from the current ADS Ratio of 1 ADS representing 3 Class A ordinary shares to a new ADS ratio of 1 ADS representing 30 Class A ordinary shares.

Chat with this insight

Recent Analyst Ratings for
$CCM

$CCM
SEC Filings

SEC Form 6-K filed by Concord Medical Services Holdings Limited

SEC Form 6-K filed by Concord Medical Services Holdings Limited

SEC Form 6-K filed by Concord Medical Services Holdings Limited

$CCM
Press Releases

Fastest customizable press release news feed in the world

Concord Medical Schedules 2024 Annual Meeting of Shareholders

Concord Medical Reports Financial Results for the First Half of 2024

Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment

$CCM
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed

$CCM
Financials

Live finance-specific insights

Concord Medical Reports Financial Results for the First Half of 2024

Concord Medical Reports Financial Results for the First Half of 2023

Concord Medical Reports Financial Results for the First Half of 2022

$CCM
Market Insights

Live Market Insights

Concord Medical Services shares are trading lower after the company announced plans to change from the current ADS Ratio of 1 ADS representing 3 Class A ordinary shares to a new ADS ratio of 1 ADS representing 30 Class A ordinary shares.

Concord Medical Announces Plan To Implement Ads Ratio Change From The Current ADS Ratio Of 1 ADS Representing 3 Class A Ordinary Shares To A New ADS Ratio Of One 1 ADS Representing 30 Class A Ordinary Shares (1-For-10)

Shares of Chinese stocks are trading lower. The U.S recently unveiled rules to curb investments in Chinese technology.

$CCM
Leadership Updates

Live Leadership Updates

Concord Medical Announces Divestment of Singapore Concord International Hospital

Concord Medical Services shares are trading lower after the company announced plans to change from the current ADS Ratio of 1 ADS representing 3 Class A ordinary shares to a new ADS ratio of 1 ADS representing 30 Class A ordinary shares.

Chat with this insight

Recent Analyst Ratings for $CCM

$CCM SEC Filings

SEC Form 6-K filed by Concord Medical Services Holdings Limited

SEC Form 6-K filed by Concord Medical Services Holdings Limited

SEC Form 6-K filed by Concord Medical Services Holdings Limited

$CCM Press Releases

Fastest customizable press release news feed in the world

Concord Medical Schedules 2024 Annual Meeting of Shareholders

Concord Medical Reports Financial Results for the First Half of 2024

Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment

$CCM Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed

$CCM Financials

Live finance-specific insights

Concord Medical Reports Financial Results for the First Half of 2024

Concord Medical Reports Financial Results for the First Half of 2023

Concord Medical Reports Financial Results for the First Half of 2022

$CCM Market Insights

Live Market Insights

Concord Medical Services shares are trading lower after the company announced plans to change from the current ADS Ratio of 1 ADS representing 3 Class A ordinary shares to a new ADS ratio of 1 ADS representing 30 Class A ordinary shares.

Concord Medical Announces Plan To Implement Ads Ratio Change From The Current ADS Ratio Of 1 ADS Representing 3 Class A Ordinary Shares To A New ADS Ratio Of One 1 ADS Representing 30 Class A Ordinary Shares (1-For-10)

Shares of Chinese stocks are trading lower. The U.S recently unveiled rules to curb investments in Chinese technology.

$CCM Leadership Updates

Live Leadership Updates

Concord Medical Announces Divestment of Singapore Concord International Hospital

Recent Analyst Ratings for
$CCM

$CCM
SEC Filings

$CCM
Press Releases

$CCM
Large Ownership Changes

$CCM
Financials

$CCM
Market Insights

$CCM
Leadership Updates